Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 6,000 | 7,665 | 2,119 | 613 | 847 |
| Cost of Goods | 778 | N/A | 0 | N/A | N/A |
| Gross Profit | 5,222 | 3,282 | 2,119 | 613 | 847 |
| Operating Expenses | 11,038 | 16,513 | 4,967 | 10,763 | 8,967 |
| Operating Income | -5,038 | -8,848 | -2,848 | -10,150 | -8,120 |
| Other Income | -14 | 320 | 374 | 109 | 165 |
| Pre-tax Income | -5,052 | -8,528 | -2,474 | -10,041 | -7,955 |
| Net Income Continuous | -5,052 | -8,528 | -2,474 | -10,041 | -7,955 |
| Net Income | $-5,052 | $-8,528 | $-2,474 | $-10,041 | $-7,955 |
| EPS Basic Total Ops | -0.60 | -1.10 | -0.30 | -1.20 | -1.00 |
| EPS Basic Continuous Ops | -0.62 | -1.05 | -0.31 | -1.24 | -0.98 |
| EPS Diluted Total Ops | -0.60 | -1.10 | -0.30 | -1.20 | -1.00 |
| EPS Diluted Continuous Ops | -0.62 | -1.05 | -0.31 | -1.24 | -0.98 |
| EBITDA(a) | $-4,160 | $-7,959 | $-2,059 | $-9,392 | $-7,423 |